Spanish scientists discover compound that can combat effects of Zika virus

Jul 24, 2017 16:55 IST

 Spanish scientists develop ‘anti-Zika drug’ Researchers from a southeastern Spanish University have announced the discovery of a molecule that could be used to combat the effects of Zika virus.

According to a statement released by the San Antonio Catholic University of Murcia on 22 July 2017, researchers from its Bioinformatics and High-Performance Computing research group have discovered that a compound called ‘novobiocin’ that was previously used as an anti-biotic countered the symptoms of the mosquito-borne disease.

"It's a drug that had been withdrawn from the market because it had lost its potency as an antibiotic, but we know it can be administered to humans," said Jos� Pedro Cer�n, a member of the research team.

 

Key Highlights

• The molecular structure of the proteins involved in the Zika virus' replication process was first described only a year ago.

• Researchers focused on an antibiotic that had been previously prescribed to fight off nosocomial infections, the infections that are acquired inside a hospital.

• The teams of both universities have now patented the molecule as an anti-Zika treatment.

• The compound, known as ‘novobiocin’ had phenomenal results when given to mice with a 100 per cent cure rate.

• The only remaining task is to figure out the correct proportion of dose needed to cure humans with a 100 per cent success rate.

The research team comprising four members including Cer�n, De Haan, Horacio P�rez S�nchez and Jorge de la Pe�a-Garc�a, make up the only Spanish team to have published papers in the field of anti-Zika drugs.

CA eBook

About Zika Virus

• The Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes.

• The symptoms experienced by those affected include mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or a headache. The duration of these symptoms is normally for 2-7 days.

• The virus was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever.

• It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania.

• Outbreaks of the disease have been recorded in Africa, the Americas, Asia and the Pacific.

• It saw a swift expansion between early 2015 and January 2016 throughout South America and the Caribbean.

• It was around the same time that factors such as tropical climates and insufficient mosquito-population control led the World Health Organization to term the disease as an epidemic and a global emergency.

Is this article important for exams ? Yes3 People Agreed
Read more Current Affairs on: Zika Virus , Molecular , Aedes , World Health Organization , Epidemic

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK